We are producing a video series of interviews with Canadian researchers working on DMD. We have met many professors, and our videos will be coming up soon. \u00a0We wish to connect you, the DMD community, with the professors. You will be delighted to know their deepest motivation and devotion. They love to know your face; you are the people that will be impacted by their discovery. Also, the video is a very good medium to offer an understanding of scientific concepts which are not always so easy to grasp.<\/p>\n
<\/p>\n
We met and interviewed professor J\u00e9r\u00f4me Frenette of the Rehabilitation Department of Laval University who is currently working on a potential treatment for Duchenne muscular dystrophy. He presented some very promising work with his team at the University Hospital Center of Quebec on osteoprotegerin (OPG).<\/p>\n
<\/p>\n
\u2022 OPG is a protein well known for its protective role against osteoporosis, where its name comes from, osteoprotegerin.
\n\u2022 OPG reduces damage and inflammation.
\n\u2022 OPG eases Duchenne muscular dystrophy, especially in fast-twitch skeletal muscle.
\n\u2022 OPG can simultaneously treat osteoporosis and muscle degeneration in patients with DMD.
\n\u2022 Dystrophic muscles can be protected without correcting the dystrophin gene. The team from the Faculty of Medicine at Laval University in Quebec City has just demonstrated that this protein could be a new avenue of treatment for Duchenne muscular dystrophy (DMD).<\/p>\n
<\/p>\n